Deutsche Bank Ag\ Immunovant, Inc. Transaction History

Deutsche Bank Ag\

$240 Billion
Q3 2024

A detailed history of Deutsche Bank Ag\ transactions in Immunovant, Inc. stock. As of the latest transaction made, Deutsche Bank Ag\ holds 149,569 shares of IMVT stock, worth $4.11 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

149,569

Previous 142,974 4.61%

Holding current value

$4.11 Million

Previous $3.77 Million 9.01%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$27.51 - $27.51 $181,428 - $181,428	6,595 Added 4.61%	149,569 $4.11 Million
Q2 2024 Aug 14, 2024	SELL	$25.1 - $31.61 $61,520 - $77,476	-2,451 Reduced 1.69%	142,974 $3.77 Million
Q1 2024 May 15, 2024	BUY	$30.27 - $43.79 $31,238 - $45,191	1,032 Added 0.71%	145,425 $4.7 Million
Q4 2023 Feb 14, 2024	BUY	$31.31 - $44.19 $3.43 Million - $4.83 Million	109,400 Added 312.63%	144,393 $6.08 Million
Q3 2023 Nov 09, 2023	SELL	$18.55 - $39.96 $2 Million - $4.3 Million	-107,689 Reduced 75.47%	34,993 $1.34 Million
Q2 2023 Aug 14, 2023	BUY	$14.2 - $23.75 $1.45 Million - $2.43 Million	102,461 Added 254.75%	142,682 $2.71 Million
Q1 2023 May 15, 2023	BUY	$15.27 - $19.72 $126,023 - $162,749	8,253 Added 25.82%	40,221 $623,000
Q4 2022 Feb 13, 2023	BUY	$6.59 - $17.75 $35,460 - $95,512	5,381 Added 20.24%	31,968 $567,000
Q3 2022 Nov 14, 2022	BUY	$3.93 - $6.37 $28,520 - $46,227	7,257 Added 37.54%	26,587 $148,000
Q2 2022 Aug 11, 2022	SELL	$3.38 - $5.65 $14,459 - $24,170	-4,278 Reduced 18.12%	19,330 $75,000
Q1 2022 May 13, 2022	SELL	$5.06 - $8.77 $622,526 - $1.08 Million	-123,029 Reduced 83.9%	23,608 $130,000
Q4 2021 Feb 11, 2022	BUY	$7.33 - $9.32 $11,346 - $14,427	1,548 Added 1.07%	146,637 $1.25 Million
Q3 2021 Nov 04, 2021	SELL	$7.01 - $11.37 $275,969 - $447,614	-39,368 Reduced 21.34%	145,089 $1.26 Million
Q2 2021 Aug 11, 2021	BUY	$9.4 - $16.85 $230,403 - $413,010	24,511 Added 15.32%	184,457 $1.95 Million
Q1 2021 May 13, 2021	BUY	$13.08 - $49.6 $1.68 Million - $6.39 Million	128,765 Added 412.96%	159,946 $2.57 Million
Q4 2020 Feb 16, 2021	BUY	$36.36 - $52.71 $367,417 - $532,634	10,105 Added 47.95%	31,181 $1.44 Million
Q3 2020 Nov 12, 2020	SELL	$22.61 - $38.9 $2.19 Million - $3.77 Million	-97,021 Reduced 82.15%	21,076 $742,000
Q2 2020 Aug 13, 2020	BUY	$13.87 - $28.44 $1.64 Million - $3.36 Million	118,097 New	118,097 $2.88 Million

Others Institutions Holding IMVT

# of Institutions

211

Shares Held

66.9M

Call Options Held

2.3M

Put Options Held

631K

View Full List

About Immunovant, Inc.

Ticker IMVT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 129,077,000
Market Cap $3.55B
Description
Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases. It develops batoclimab, a novel fully human monoclonal antibody that selectively binds to and inhibits the neonatal fragment crystallizable receptor, which is in Phase IIa clinical trials for the treatment of mya...

More about IMVT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account